Ucb SA
F:UNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Ucb SA
F:UNC
|
BE |
|
Braskem SA
F:BRD
|
BR |
|
Casa Minerals Inc
F:0CM
|
CA |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
F
|
Firan Technology Group Corp
F:22F
|
CA |
|
Firma Oponiarska Debica SA
F:FD8
|
PL |
|
A
|
AMAG Austria Metall AG
XMUN:AM8
|
AT |
|
Bankwell Financial Group Inc
F:33W
|
US |
|
Iida Group Holdings Co Ltd
OTC:ANTOF
|
JP |
|
State Bank of India
NSE:SBIN
|
IN |
|
C
|
Compagnie de Saint Gobain SA
XMUN:GOB
|
FR |
|
Euronext Athens Holding SA
F:HEE
|
GR |
|
Tokyo Metro Co Ltd
F:XO7
|
JP |
|
Shine Justice Ltd
F:K6Z
|
AU |
|
Kraft Bank ASA
F:709
|
NO |
|
T
|
Trip.com Group Ltd
OTC:TRPCF
|
SG |
|
Cortelco Systems Puerto Rico Inc
OTC:CPROF
|
PR |
|
C
|
Calgro M3 Holdings Ltd
F:5C2
|
ZA |
|
Columbia Care Inc
F:3LP
|
US |
|
C
|
CTS Eventim AG & Co KgaA
F:EVD
|
DE |
|
Centrale del Latte d'Italia SpA
MIL:CLI
|
IT |
|
Addex Therapeutics Ltd
F:APE
|
CH |
|
T
|
Trip.com Group Ltd
F:CLV
|
SG |
|
Z
|
Zinc of Ireland NL
F:39G
|
AU |
Bankruptcy Probability
Ucb SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ucb SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
Ucb SA
XBRU:UCB
|
38.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ucb SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ucb SA has total debt of 3.5B EUR. This includes both short-term (150m EUR) and long-term (3.4B EUR) debt.
You can find a full breakdown on its Balance Sheet.